MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2018 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
88.8 M |
Marktkapitalisierung |
$ 28.6 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Stoke Therapeutics
STOK
|
$ 26.0 | 0.46 % | $ 1.54 B | Nasdaq Global Select Market,SPB | USA |
 |
Sutro Biopharma
STRO
|
$ 16.11 | 0.06 % | $ 137 M | Nasdaq Global Select Market | USA |
 |
Shattuck Labs
STTK
|
$ 6.82 | 4.28 % | $ 475 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 43.04 | 4.55 % | $ 2.43 B | Nasdaq Global Select Market,SPB | USA |
 |
Savara
SVRA
|
$ 5.16 | 1.57 % | $ 1.15 B | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 3.01 | 7.12 % | $ 2.05 M | Nasdaq Global Select Market |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 18.19 | 0.21 % | $ 28.7 B | NYSE |  Japan |
 |
Protara Therapeutics
TARA
|
$ 3.05 | 0.31 % | $ 131 M | Nasdaq Global Market | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 78.61 | 2.5 % | $ 3.28 B | Nasdaq Global Select Market | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.47 | 0.12 % | $ 11.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Tenax Therapeutics
TENX
|
$ 1.89 | 2.72 % | $ 74.1 M | Nasdaq Global Select Market | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 39.6 | 0.05 % | $ 45.3 B | NYSE |  Israel |
 |
TG Therapeutics
TGTX
|
$ 55.78 | 0.07 % | $ 8.05 B | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 9.74 | 0.93 % | $ 82.9 M | Nasdaq Global Select Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 14.32 | 0.38 % | $ 1.93 B | Nasdaq Global Market | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.87 | 0.1 % | $ 1.56 B | Nasdaq Global Select Market | USA |
 |
UroGen Pharma Ltd.
URGN
|
$ 40.63 | 0.44 % | $ 1.95 B | Nasdaq Global Select Market | Israel |
 |
United Therapeutics Corporation
UTHR
|
$ 541.89 | 12.55 % | $ 24 B | Nasdaq Global Select Market,SPB | USA |
 |
Vericel Corporation
VCEL
|
$ 40.14 | 0.92 % | $ 2.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 46.04 | 0.89 % | $ 3.62 B | Nasdaq Global Market,SPB | USA |
 |
Vir Biotechnology
VIR
|
$ 11.18 | 4.98 % | $ 1.55 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 32.6 | 2.48 % | $ 3.67 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.91 | 0.8 % | $ 289 M | Nasdaq Global Select Market,SPB | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 4.8 | 7.51 % | $ 51.1 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 20.59 | 2.98 % | $ 2.1 B | Nasdaq Capital Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 522.81 | 0.07 % | $ 134 B | Nasdaq Global Select Market,SPB | USA |
 |
Verastem
VSTM
|
$ 8.05 | 1.64 % | $ 558 M | Nasdaq Global Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.31 | 3.29 % | $ 11.8 M | Nasdaq Global Select Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 30.84 | 2.8 % | $ 122 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 2.68 | 1.52 % | $ 157 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.7 | 1.65 % | $ 624 M | Nasdaq Global Select Market |  Singapore |
 |
Xenetic Biosciences
XBIO
|
$ 2.32 | 2.65 % | $ 3.95 M | Nasdaq Capital Market | USA |
|
XBiotech
XBIT
|
$ 2.19 | 0.46 % | $ 66.8 M | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.19 | 4.38 % | $ 7.49 M | Nasdaq Capital Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 37.19 | 0.24 % | $ 2.95 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 9.56 | 1.53 % | $ 1.53 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 2.9 | 0.17 % | $ 123 M | Nasdaq Capital Market | USA |
 |
Xencor
XNCR
|
$ 24.95 | 0.86 % | $ 1.85 B | Nasdaq Global Select Market,SPB | USA |
 |
22nd Century Group
XXII
|
$ 0.84 | 4.78 % | $ 155 K | NYSE American | USA |
 |
Zai Lab Limited
ZLAB
|
$ 26.34 | 1.58 % | $ 28.9 B | Nasdaq Global Select Market | China |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 2.77 | 2.03 % | $ 199 M | Nasdaq Global Market | USA |
 |
Zoetis
ZTS
|
$ 69.83 | 0.07 % | $ 31 B | NYSE,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | Canada |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |